LAMISIL

Google image searchProduct monograph

Active ingredient

terbinafine hydrochloride, 1 %/W/W

DIN: 02238703

Dosage form(s): SPRAY

Route(s) of administration: TOPICAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 05-JAN-1999

ATC:

• D01 — ANTIFUNGALS FOR DERMATOLOGICAL USE (ATC, ATC/DDD, )
• D01A — ANTIFUNGALS FOR TOPICAL USE (ATC, ATC/DDD)
• D01AE — Other antifungals for topical use (ATC, ATC/DDD)
• D01AE15 — TERBINAFINE (ATC/DDD)

Reference brand drug: Lamisil

Pharmaceutical standard: MFR

External Links for Lamisil

Search on Google

• Lamisil side effects
• Lamisil dosage
• terbinafine hydrochloride side effects
• terbinafine hydrochloride dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find lamisil photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.